معرفی
Robert Leibenluft serves as a Professorial Lecturer in Law at The George Washington University Law School while concurrently practicing as a partner at Hogan Lovells, LLP in Washington, DC. His dual career spans academia and high-stakes legal practice specializing in health sector antitrust regulation.
Leibenluft earned his BA from Yale University and JD from the University of California at Berkeley. His professional trajectory includes foundational work as an attorney advisor in the FTC's Office of Policy Planning, partnership at Hogan & Hartson (now Hogan Lovells), and pivotal government service as Assistant Director for Health Care in the FTC's Bureau of Competition where he supervised 25-30 staff reviewing health care mergers and antitrust conduct.
His research concentrates on the critical intersection of health care policy and antitrust enforcement, particularly examining hospital-physician integration, pharmaceutical competition, and regulatory frameworks for medical device manufacturers. This expertise manifests through frequent publications in premier journals including Health Affairs and The New England Journal of Medicine, establishing him as a leading authority in health law jurisprudence.
Leibenluft maintains significant professional leadership through roles as inaugural Fellow and former Vice-President of the American Health Lawyers Association, former committee chair for multiple ABA Antitrust Section divisions, and current Board Chair of Health Care Incentives Institute, Inc. (HCI3) which oversees Prometheus Payment and Bridges-to-Excellence initiatives.
